Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
The institution will be spread over an area of more than 8 acres
Women emerge as the cornerstone of this monumental undertaking
These approvals mark significant progress for Venus Remedies in expanding its market presence
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Subscribe To Our Newsletter & Stay Updated